Natural Alternatives International, Inc. (NAII) News
Filter NAII News Items
NAII News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
NAII News Highlights
- NAII's 30 day story count now stands at 2.
- Over the past 21 days, the trend for NAII's stories per day has been choppy and unclear. It has oscillated between 1 and 1.
- SR are the most mentioned tickers in articles about NAII.
Latest NAII News From Around the Web
Below are the latest news stories about NATURAL ALTERNATIVES INTERNATIONAL INC that investors may wish to consider to help them evaluate NAII as an investment opportunity.
Here's What's Concerning About Natural Alternatives International's (NASDAQ:NAII) Returns On CapitalIf we want to find a stock that could multiply over the long term, what are the underlying trends we should look for... |
NEWLY PUBLISHED STUDY SHOWS SR CARNOSYN® BETA-ALANINE IMPROVES COGNITIVE FUNCTION IN OLDER ADULTSNatural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), an international leader in custom contract nutritional supplement manufacturing for over four decades, today announced that new research on the cognitive benefits of SR CarnoSyn® beta-alanine tablets, a patented sustained release delivery system owned by NAI, has been published in Nutrients. |
Natural Alternatives International, Inc. Announces 2023 Q2 and YTD ResultsNatural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced net income of $1.8 million, or $0.31 per diluted share, on net sales of $42.3 million for the second quarter of fiscal year 2023 compared to net income of $1.8 million, or $0.30 per diluted share, in the second quarter of the prior fiscal year. |
Natural Alternatives International's (NASDAQ:NAII) earnings have declined over year, contributing to shareholders 28% lossNatural Alternatives International, Inc. ( NASDAQ:NAII ) shareholders should be happy to see the share price up 19% in... |
The 7 Best Stocks Under $15 to Buy NowDoes inflation have you down? |
Natural Alternatives International, Inc. Announces a $1 Million Increase in its Stock Repurchase PlanNatural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer and marketer of customized nutritional supplements, today announced its Board of Directors authorized a $1.0 million increase to its stock repurchase plan bringing the total plan authorized repurchase amount to $19.0 million. Under the repurchase plan, NAI may, from time to time, purchase shares of its common stock, depending upon market conditions, in open market or privately negotiated transacti |
Increases to Natural Alternatives International, Inc.'s (NASDAQ:NAII) CEO Compensation Might Cool off for nowCEO Mark LeDoux has done a decent job of delivering relatively good performance at Natural Alternatives International... |
Natural Alternatives International, Inc. Announces 2023 Q1 ResultsNatural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced net income of $1.1 million, or $0.18 per diluted share, on net sales of $43.1 million for the first quarter of fiscal year 2023 compared to net income of $3.3 million, or $0.51 per diluted share, in the first quarter of the prior fiscal year. |
Natural Alternatives International (NASDAQ:NAII) Could Be Struggling To Allocate CapitalIf you're looking for a multi-bagger, there's a few things to keep an eye out for. Amongst other things, we'll want to... |
Natural Alternatives International, Inc. Announces 2022 Q4 and YTD ResultsNatural Alternatives International, Inc. ("NAI") (Nasdaq: NAII), a leading formulator, manufacturer, and marketer of customized nutritional supplements, today announced net income of $3.1 million, or $0.52 per diluted share, on net sales of $52.5 million for the fourth quarter of fiscal year 2022 compared to net income of $3.0 million, or $0.47 per diluted share, in the fourth quarter of the prior fiscal year. |